tiprankstipranks
Neuronetics Inc (STIM)
NASDAQ:STIM
US Market
Want to see STIM full AI Analyst Report?

Neuronetics (STIM) Blogger Opinions & Sentiment

388 Followers

Blogger Sentiment

Bullish: 66.67%
Sector Average
Bullish
STIM Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
33% SeekingAlpha
33% GuruFocus
34% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Wednesday’s insider buys and sells: Cloudflare executive cashes out $27M
Investing
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Insider Buying: Jorey Chernett Acquires 35,000 Shares of Neuronetics Inc (STIM)
GuruFocus
Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of STIM?
Seeking Alpha’s David Zanoni has a Bullish Sentiment.
    What do Motley Fool contributors think of STIM?
    Currently there's no blogger sentiment for STIM.
    What Is STIM’s Blogger Sentiment?
    STIM’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for STIM?
      The most recent blogger prediction for STIM was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          IOVAIovance Biotherapeutics
          VERAVera Therapeutics
          KURAKura Oncology
          NUVBNuvation Bio
          DFTXDefinium Therapeutics